Your browser doesn't support javascript.
loading
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Creasey, Thomas; Barretta, Emilio; Ryan, Sarra L; Butler, Ellie; Kirkwood, Amy A; Leongamornlert, Daniel; Papaemmanuil, Elli; Patrick, Pip; Clifton-Hadley, Laura; Patel, Bela; Menne, Tobias; McMillan, Andrew K; Harrison, Christine J; Rowntree, Clare J; Morley, Nick; Marks, David I; Fielding, Adele K; Moorman, Anthony V.
Affiliation
  • Creasey T; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne. tom.creasey@ncl.ac.uk.
  • Barretta E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Ryan SL; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Butler E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Kirkwood AA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute University College London.
  • Leongamornlert D; Sanger Institute, Cambridge.
  • Papaemmanuil E; Memorial Sloan Kettering Cancer Center, New York.
  • Patrick P; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute University College London.
  • Clifton-Hadley L; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute University College London.
  • Patel B; Department of Haematology, Queen Mary University of London, London.
  • Menne T; Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
  • McMillan AK; Department of Haematology, Nottingham University Hospital NHS Trust, Nottingham.
  • Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Rowntree CJ; Department of Haematology, Cardiff And Vale University Health Board, Cardiff.
  • Morley N; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
  • Marks DI; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol.
  • Fielding AK; UCL Cancer Institute, London.
  • Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne. anthony.moorman@ncl.ac.uk.
Haematologica ; 107(9): 2051-2063, 2022 09 01.
Article de En | MEDLINE | ID: mdl-34788984

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Child / Humans / Middle aged Langue: En Journal: Haematologica Année: 2022 Type de document: Article Pays de publication: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Child / Humans / Middle aged Langue: En Journal: Haematologica Année: 2022 Type de document: Article Pays de publication: Italie